AstraZeneca will list shares directly in New York, but isn't leaving the UK
Amid concerns it might leave the UK, the pharma giant reaffirmed its commitment to the country, keeping its headquarters, primary listing, and tax base there.
Amid concerns it might leave the UK, the pharma giant reaffirmed its commitment to the country, keeping its headquarters, primary listing, and tax base there.
What's Your Reaction?
